AIM ImmunoTech
12 hedge funds and large institutions have $544K invested in AIM ImmunoTech in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
25% more capital invested
Capital invested by funds: $434K → $544K (+$110K)
25% less funds holding
Funds holding: 16 → 12 (-4)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$75.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$73.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$23K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18K |
| 3 |
VF
Virtu Financial
New York
|
-$12.5K |
| 4 |
Renaissance Technologies
New York
|
-$9K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $181K | -$2.09K | -1 | -1% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $178K | +$75.2K | +36 | +54% |
|
|
3
Citadel Advisors
Miami,
Florida
| $79K | +$73.1K | +35 | +318% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $29K | – | – | – |
|
5
Creative Planning
Overland Park,
Kansas
| $16K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $14K | -$12.5K | -6 | -43% |
|
7
Northern Trust
Chicago,
Illinois
| $13K | – | – | – |
|
|
TSS
8
Two Sigma Securities
New York
| $11K | -$23K | -11 | -61% |
|
|
GC
9
Guggenheim Capital
Chicago,
Illinois
| $8K | – | – | – |
|
|
OAM
10
Occidental Asset Management
Burlingame,
California
| $6K | – | – | – |
|
11
Bank of New York Mellon
New York
| $4K | -$2.09K | -1 | -33% |
|
|
WPW
12
Waldron Private Wealth
Bridgeville,
Pennsylvania
| $4K | – | – | – |
|
13
UBS Group
Zurich,
Switzerland
| $1K | -$2.09K | -1 | Closed |
|
|
14
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$18K | -12 | Closed |
|
|
15
Renaissance Technologies
New York
| – | -$9K | -6 | Closed |
|
|
16
Wells Fargo
San Francisco,
California
| – | -$7K | -5 | Closed |
|
AIM Hedge Fund Activity: Q1 2018 in Review
12 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q1 2018, worth a combined $544K — up 25% from $434K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AIM and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Vanguard Group, adding an estimated $75.2K. The largest seller was Two Sigma Securities, cutting an estimated $23K.
- 12 institutional investors held AIM ImmunoTech (AIM) as of Q1 2018, down from 16 in Q4 2017.
- Funds reported $544K of AIM ImmunoTech stock for Q1 2018, up 25% quarter-over-quarter.
- 0 funds opened new AIM ImmunoTech positions in Q1 2018 and 4 closed out, a net change of -4 holders.
- The largest AIM ImmunoTech buyer in Q1 2018 was Vanguard Group, an estimated $75.2K added.
- The largest AIM ImmunoTech seller in Q1 2018 was Two Sigma Securities, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2018.